ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 51 - 60 of 64
Credit(s): PDHs: 4.0, ASHA CEUs*: 0.4
Summary: The first article in this SIG 18 activity investigates the applications speech-language pathologists (SLPs) and audiologists used most frequently during the beginning of the COVID-19 pandemic. It also discusses the main obstacles to providing speech, language, and hearing services through telepractice. Through the international distribution of an electronic survey, a total of 1,466 surveys from SLPs and audiologists from 40 countries were used for the analysis. The second article discusses the Auditory Verbal UK's training program for prospective listening and spoken language specialist certified auditory verbal therapists delivered globally via telepractice. The article explores, from a global perspective, audiology and early intervention services and perspectives regarding telepractice. The third article explores parents' and therapists' views of the benefits and challenges of telepractice for early intervention for children who are deaf or hard of hearing during the COVID-19 pandemic. Through survey and analysis, the article probes the views of parents, Listening and Spoken Language Specialist Certified Auditory Verbal Therapists in using telepractice to deliver auditory verbal sessions.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Presenter(s): Amyn M. Amlani, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The degree of hearing aid adoption as a treatment to lessen communication difficulties has remained essentially unchanged over the past four decades. This session will share evidence and hands-on tools that promote opportunities for evaluating and modifying patient readiness, with the intent of enhancing the adoption of professional audiology services and amplification technologies.
Presenter(s): Dave Fabry, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is no question that emerging technologies such as embedded sensors and artificial intelligence are changing the hearing health landscape. This session will look ahead to the coming decade and explore innovations in hearing health care technology, strategy, and service. The speaker will discuss practical ways to leverage these innovations to be successful in today’s and tomorrow’s dynamic market landscape.
Presenter(s): Stephanie Feller; Akbar Razvi, AuD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session covers a unique case of bilateral temporal bone fractures: one that spares the otic capsule yet presents with a large sensorineural component. The speaker describes the anatomy and physiology of the temporal bone to provide background information about potential structures that can be damaged in a fracture as well as explain the varying etiologies of temporal bone fractures (TBF). In addition, this session discusses possible outcomes from a TBF in relation to hearing loss and facial nerve function and potential implications for treatment, including cochlear implantation.
Presenter(s): Devin L. McCaslin, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session will examine the diagnosis and treatment of persistent postural-perceptual dizziness (PPPD). The session will explore the recently defined criteria for the presentation and symptoms of the disorder as well as describe current and emerging research that is helping clinicians and researchers better understand it. The speaker will also discuss how chronic co-morbid disorders such as migraine and Meniere’s disease should be factored into the treatment of this disorder.
Presenter(s): De Wet Swanepoel; Karina De Sousa
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course discusses validated technologies for remote hearing screening in the digital age, including options for no-touch screening with uncalibrated equipment and low-touch remote screening. The course is part of a set of practical programs that address specific aspects of remote practice in audiology.
Presenter(s): Meaghan Reed, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: It is unclear how over-the-counter hearing devices will impact our patients and our practices in the coming years. This session will discuss practical strategies for incorporating OTC devices, deciding when to offer alternative rehabilitation options to patients, and offering a wider variety of solutions to meet our patients’ needs.
Presenter(s): Steven Thomas Kulsar, PhD, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session focuses on the use of in-situ measures and development of patient amplification prescriptions. The importance of in-situ measures is widely overlooked or misunderstood. Dissecting the benefits of this and other built-in manufacturer software features will provide opportunity for significant improvement in fitting outcomes and patient satisfaction over conventional first-fit settings.
Presenter(s): Margaret Kenna; Amanda M Griffin; Charlotte Morse-Fortier; Kelly N Jahn; David Faller; Julie Gayle Arenberg; Michael A Cohen; Elizabeth DesRoche
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: There is evidence that many factors contribute to the varied performance outcomes among pediatric cochlear implant (CI) recipients, including etiology and quality of the electrode neuron interfaces (ENI). This course examines a study that investigated the intersection of these factors by analyzing the records and device settings for 156 children with confirmed diagnoses of either enlarged vestibular aqueduct (EVA) or Connexin-26 mutations.
<< 1 2 3 4 5 6 7 >>